Table 1. Baseline characteristics of control and INOCA groups.

	Group 0 (Control Group) (n:212)		Group 1 (INOCA Patients) (n:212)		All Patients		p
Age (years)	57	±12	54	±9	56	±11	0.158
Sex, n (%) (Female)	137	(64.6)	139	(65.6)	276	(65.1)	0.839
Smoking, n (%)	96	(45.3)	94	(44.3)	190	(44.8)	0.845
Family CAD history, n (%)	33	(15.6)	64	(30.2)	97	(22.9)	<0.001
Hypertension, n (%)	90	(42.5)	89	(42.0)	179	(42.2)	0.922
Diabetes, n (%)	40	(18.9)	43	(20.3)	83	(19.6)	0.714
Hemoglobin (g/dL)	13.77	±1.54	14.91	±1.67	14h34	±1.70	<0.001
RDW	12.5	±1.9	13.5	±1.6	13	±1.8	<0.001
Platelet (10^3/mL)	252	±66	271	±71	261	±69	<0.001
MPV	8.72	±5.29	9.92	±1.11	9h32	3.86	<0.001
Lymphocyte (10^3/mL)	2.62	±0.91	2.35	±1.04	2.488	±0.985	<0.001
Neutrophil (10^3/mL)	4.54	±1.44	4.92	±1.90	4.728	±1.695	0.034
PLR	103.38	±34.19	126.36	±47.48	114.87	42.89	<0.001
SII	169.59	(114.84-249.52)	234.86	(162.38-377.12)	200.50	(134.61-319.78)	<0.001
NLR	1.75	(1.42-2.21)	2.06	(1.55-2.71)	1.89	(1.47-2.47)	<0.001
MHR	0.00115	(0.0090-0.0175)	0.0095	(0.0072-0.0127)	0.0108	(0.0080-0.0142)	<0.001
Glucose (mg/dL)	98	±23	113	±40	106	±34	<0.001
Total Cholesterol (mg/dL)	176	±41	194	±46	185	±44	<0.001
Triglyceride (mg/L)	127	(90-165)	144	(102-198)	137	(98-189)	0.005
LDL-C (mg/dL)	102	±38	117	±43	110	±41	<0.001
HDL-C (mg/dL)	48	±12	46	±12	47	±12	0.179
Urea (mg/dL)	28.08	±8.097	15.04	±10.40	21h57	±11.36	<0.001
Creatine (mg/dL)	0.71	(0.62-0.83)	0.70	(0.60-0.90)	0.77	±0.45	0.056
hs-CRP (mg/L)	2.3	(1.1-4.4)	4.5	(3.1-8.9)	3.6	(1.6-6.9)	<0.001
EF (%)	64	±4	61	±8	62	±7	<0.001

INOCA: ischaemia with Non-obstructive Coronary Arteries; CAD: coronary artery disease; RDW: red blood cell distribution width; MPV: mean platelet volume; PLR: platelet to lymphocyte ratio; SII: systemic immune-inflammation index; NLR: neutrophil to lymphocyte ratio; MHR: monocyte/HDL-C ratio; LDL-C: Low-Density Lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; hsCRP: high sensitive C-Reactive Protein; EF: ejection fraction.